236 related articles for article (PubMed ID: 31499197)
1. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
[TBL] [Abstract][Full Text] [Related]
2. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
[TBL] [Abstract][Full Text] [Related]
3. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.
Yin S; Xia C; Wang Y; Wan D; Rao J; Tang X; Wei J; Wang X; Li M; Zhang Z; Liu J; He Q
J Control Release; 2018 Oct; 288():148-160. PubMed ID: 30099017
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
[TBL] [Abstract][Full Text] [Related]
5. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
6. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis.
Ren K; He J; Qiu Y; Xu Z; Wang X; Li J; Zang S; Yang Y; Li J; Long Y; Zhang Z; Li M; He Q
Acta Biomater; 2022 Jun; 145():185-199. PubMed ID: 35447368
[TBL] [Abstract][Full Text] [Related]
7. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity.
Wang X; Qiu Y; Yu Q; Li H; Chen X; Li M; Long Y; Liu Y; Lu L; Tang J; Zhang Z; He Q
Int J Pharm; 2018 Jan; 536(1):1-10. PubMed ID: 28887220
[TBL] [Abstract][Full Text] [Related]
8. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer.
Xia T; He Q; Shi K; Wang Y; Yu Q; Zhang L; Zhang Q; Gao H; Ma L; Liu J
Pharm Dev Technol; 2018 Jan; 23(1):13-21. PubMed ID: 27884084
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two methods for tumour-targeting peptide modification of liposomes.
Huang SQ; Zhang HM; Zhang YC; Wang LY; Zhang ZR; Zhang L
Acta Pharmacol Sin; 2023 Apr; 44(4):832-840. PubMed ID: 36271156
[TBL] [Abstract][Full Text] [Related]
10. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
[TBL] [Abstract][Full Text] [Related]
11. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma.
Fei N; Wen S; Ramanathan R; Hogg ME; Zureikat AH; Lotze MT; Bahary N; Singhi AD; Zeh HJ; Boone BA
Clin Transl Sci; 2021 Sep; 14(5):1822-1829. PubMed ID: 34002944
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
14. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
15. A novel antitumour strategy using bidirectional autophagic vesicles accumulation via initiative induction and the terminal restraint of autophagic flux.
Wang Y; Tai X; Zhang L; Liu Y; Gao H; Chen J; Shi K; Zhang Q; Zhang Z; He Q
J Control Release; 2015 Feb; 199():17-28. PubMed ID: 25499918
[TBL] [Abstract][Full Text] [Related]
16. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.
Li Z; Liu C; Li C; Wang F; Liu J; Zheng Z; Wu J; Zhang B
J Nanobiotechnology; 2021 Dec; 19(1):421. PubMed ID: 34906155
[TBL] [Abstract][Full Text] [Related]
18. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment.
Ji Y; Liu X; Li J; Xie X; Huang M; Jiang J; Liao YP; Donahue T; Meng H
Nat Commun; 2020 Aug; 11(1):4249. PubMed ID: 32843618
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
20. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.
Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C
ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
